CompletedPhase 3NCT04283578

Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome

Studying Prader-Willi syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Toulouse
Principal Investigator
Maithé TAUBER, MD
University Hospital, Toulouse
Intervention
OT(drug)
Enrollment
52 enrolled
Eligibility
All sexes
Timeline
2020 – 2022

Study locations (7)

Collaborators

International Clinical Trials Association · Epidemiological and Clinical Research Information Network

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04283578 on ClinicalTrials.gov

Other trials for Prader-Willi syndrome

Additional recruiting or active studies for the same condition.

See all trials for Prader-Willi syndrome →

← Back to all trials